NEW YORK (GenomeWeb News) – Pharsight has signed up Inforsense to distribute its products in China through its subsidiary in Shanghai.
 
Under the agreement, Inforsense will market Pharsight’s software, which is used in pharmacokinetic and pharmacodynamic analysis, reporting, archiving, and data visualization. Inforsense will distribute the software in the Chinese pharmaceutical and biotech research and development market, and conduct sales and marketing, end-user training, and maintenance and support services.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.